| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661c68977a99ccd5a68ea29d1b870a1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd68b6abed7ab6cc663824cbb6e7c9c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-00 |
| filingDate |
2012-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec33f3234c203cee203b259bad00adf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ec3f67690c4025995bf7f7286ee0063 |
| publicationDate |
2013-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013059163-A1 |
| titleOfInvention |
2,5-disubstituted thiomorpholine orexin receptor antagonists |
| abstract |
The present invention is directed to 2,5-disubstituted thiomorpholine amide compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the 2,5-disubstituted thiomorpholine amide compounds described herein in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017194548-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11667644-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11059828-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3980406-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828302-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10221170-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434236-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9556190-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9440982-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9499517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11241432-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9586934-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9617246-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9676751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10894789-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9896452-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015088865-A1 |
| priorityDate |
2011-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |